Toggle light / dark theme

Monkeyflowers glow in a rich assortment of colors, from yellow to pink to deep red-orange. But about 5 million years ago, some of them lost their yellow. In the Feb. 10 issue of Science, UConn botanists explain what happened genetically to jettison the yellow pigment, and the implications for the evolution of species.

Monkeyflowers are famous for growing in harsh, mineral-rich soils where other plants can’t. They are also famously diverse in shape and color. Monkeyflowers also provide a textbook example of how a single-gene change can make a . In this case, a monkeyflower species lost the yellow pigments in the petals but gained pink about 5 million years ago, attracting bees for pollination. Later, a descendent species accumulated mutations in a gene called YUP that recovered the yellow pigments and led to production of red flowers. The species stopped attracting bees. Instead, hummingbirds pollinated it, isolating the red flowers genetically and creating a new species.

UConn botanist Yaowu Yuan and postdoctoral researcher Mei Liang (currently a professor at South China Agricultural University), with collaborators from four other institutes, have now shown exactly which gene changed to prevent monkeyflowers from making yellow. Their research, published this week in Science, adds weight to a theory that new genes create phenotypic diversity and even new species.

Seminar summary: https://foresight.org/summary/bioelectric-networks-taming-th…-medicine/
Program & apply to join: https://foresight.org/biotech-health-extension-program/

Foresight Biotech & Health Extension Meeting sponsored by 100 Plus Capital.

Michael Levin, Tufts Center for Regenerative and Developmental Biology.
Bioelectric Networks: Taming the Collective Intelligence of Cells for Regenerative Medicine.

Michael Levin, Distinguished Professor in the Biology department and Vannevar Bush Chair, serves as director of the Tufts Center for Regenerative and Developmental Biology. Recent honors include the Scientist of Vision award and the Distinguished Scholar Award. His group’s focus is on understanding the biophysical mechanisms that implement decision-making during complex pattern regulation, and harnessing endogenous bioelectric dynamics toward rational control of growth and form. The lab’s current main directions are:

Chinese geneticist He Jiankui rocked the scientific world with his gene-edited baby experiments back in 2018, a highly controversial use of the technology that ended up sending him to a three-year stint in prison for illegal medical practices.

Now, just under a year after being released, He has some regrets about rushing into the experiments.

“I did it too quickly,” He told the South China Morning Post in a new interview.

Targeting calcium signaling in neurons represents a promising therapeutic approach for treating a rare form of schizophrenia, according to a Northwestern Medicine study published in Biological Psychiatry.

“This is the first time that human are made and characterized from with the 16p11.2 duplication, one of the most prominent genetic risk factors in schizophrenia, and the first time that signaling is found as a central abnormality in schizophrenia neurons,” said Peter Penzes, Ph.D., the Ruth and Evelyn Dunbar Professor of Psychiatry and Behavioral Sciences and senior author of the study.

Schizophrenia is characterized by auditory and visual hallucinations, delusions, and trouble with forming and sorting thoughts, which severely impacts productivity and overall quality of life. The disease, which affects roughly one percent of the , has strong genetic associations, however the exact genes involved are unknown.

Advancing Geroscience & Gerotherapeutics — Dr. Nir Barzilai, MD, Albert Einstein College of Medicine.


Dr. Nir Barzilai, MD (https://www.einsteinmed.edu/faculty/484/nir-barzilai/) is the Director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is the Ingeborg and Ira Leon Rennert Chair of Aging Research, professor in the Departments of Medicine and Genetics, and member of the Diabetes Research Center and of the Divisions of Endocrinology & Diabetes and Geriatrics.

Dr. Barzilai’s research interests are in the biology and genetics of aging, with one focus of his team on the genetics of exceptional longevity, where they hypothesize and demonstrate that centenarians (those aged 100 and above) may have novel protective genes, which allow the delay of aging or for the protection against age-related diseases. The second focus of his work, for which Dr. Barzilai holds an NIH Merit award, is on the metabolic decline that occurs during aging, and his team hypothesizes that the brain leads this decline with some very interesting neuro-endocrine connections.

It sounds like the start of a Southern gothic horror thriller. Auburn University scientists have been putting alligator DNA in catfish. It’s delicious, but with less chance for infection. Don’t worry, it won’t bite back. MIT Technology Review recently highlighted the work of Rex Dunham, Baofeng Su and their colleagues at Auburn University, who have used genetic modification to reduce problems of disease in catfish farming.

Synthetic biology has made major strides towards the holy grail of fully programmable bio-micromachines capable of sensing and responding to defined stimuli regardless of their environmental context. A common type of bio-micromachines is created by genetically modifying living cells.[ 1 ] Living cells possess the unique advantage of being highly adaptable and versatile.[ 2 ] To date, living cells have been successfully repurposed for a wide variety of applications, including living therapeutics,[ 3 ] bioremediation,[ 4 ] and drug and gene delivery.[ 5, 6 ] However, the resulting synthetic living cells are challenging to control due to their continuous adaption and evolving cellular context. Application of these autonomously replicating organisms often requires tailored biocontainment strategies,[ 7-9 ] which can raise logistical hurdles and safety concerns.

In contrast, nonliving synthetic cells, notably artificial cells,[ 10, 11 ] can be created using synthetic materials, such as polymers or phospholipids. Meticulous engineering of materials enables defined partitioning of bioactive agents, and the resulting biomimetic systems possess advantages including predictable functions, tolerance to certain environmental stressors, and ease of engineering.[ 12, 13 ] Nonliving cell-mimetic systems have been employed to deliver anticancer drugs,[ 14 ] promote antitumor immune responses,[ 15 ] communicate with other cells,[ 16, 17 ] mimic immune cells,[ 18, 19 ] and perform photosynthesis.